Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with CeftolozaneBrian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
The International Journal of Eating Disorders|November 21, 2024
Using Bomb Calorimetry to Investigate Intestinal Energy Harvest in Anorexia Nervosa: Preliminary Findings on Stool Calorie LossKylie K Reed, Emily C Bulik-Sullivan, Yunzhi Qian, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studiesC R Rayner, C C Bulik, M A Kamal, et al.
Gut Microbes|March 26, 2021
Gut microbial communities from patients with anorexia nervosa do not influence body weight in recipient germ-free miceElaine M Glenny, Farnaz Fouladi, Stephanie A Thomas, et al.
Digital Health|November 10, 2025
Evaluation of race, ethnicity, and language mischaracterizations in the electronic medical record for Hispanic/Latinx patientsRicardo Crespo Regalado, Emily C Bulik-Sullivan, Andrew G Blank, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection modelBrian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection ModelAnthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzaeSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Nutrients|November 11, 2022
Development and Validation of an Eating-Related Eco-Concern QuestionnaireBaiyu Qi, Emily K Presseller, Gabrielle E Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial CarcinomaWilliam F Maguire, Daniel Lee, Chana Weinstock, et al.
Pageof 5